Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 3
2005 1
2006 3
2008 4
2009 3
2010 3
2011 1
2012 3
2013 2
2014 2
2015 4
2016 3
2017 2
2020 1
2021 5
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
Elias AD, Spoelstra NS, Staley AW, Sams S, Crump LS, Vidal GA, Borges VF, Kabos P, Diamond JR, Shagisultanova E, Afghahi A, Mayordomo J, McSpadden T, Crawford G, D'Alessandro A, Zolman KL, van Bokhoven A, Zhuang Y, Gallagher RI, Wulfkuhle JD, Petricoin Iii EF, Gao D, Richer JK. Elias AD, et al. Among authors: spoelstra ns. NPJ Breast Cancer. 2023 May 20;9(1):41. doi: 10.1038/s41523-023-00544-z. NPJ Breast Cancer. 2023. PMID: 37210417 Free PMC article.
The role of miRNAs in progesterone action.
Cochrane DR, Spoelstra NS, Richer JK. Cochrane DR, et al. Among authors: spoelstra ns. Mol Cell Endocrinol. 2012 Jun 24;357(1-2):50-9. doi: 10.1016/j.mce.2011.09.022. Epub 2011 Sep 17. Mol Cell Endocrinol. 2012. PMID: 21952083 Review.
NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer.
O'Neill KI, Kuo LW, Williams MM, Lind H, Crump LS, Hammond NG, Spoelstra NS, Caino MC, Richer JK. O'Neill KI, et al. Among authors: spoelstra ns. Cancers (Basel). 2022 Jul 21;14(14):3543. doi: 10.3390/cancers14143543. Cancers (Basel). 2022. PMID: 35884604 Free PMC article.
Blocking tryptophan catabolism reduces triple-negative breast cancer invasive capacity.
Kuo LW, Crump LS, O'Neill K, Williams MM, Christenson JL, Spoelstra NS, Roy MK, Argabright A, Reisz JA, D'Alessandro A, Boorgula MP, Goodspeed A, Bickerdike M, Bitler BG, Richer JK. Kuo LW, et al. Among authors: spoelstra ns. Cancer Res Commun. 2024 Sep 23. doi: 10.1158/2767-9764.CRC-24-0272. Online ahead of print. Cancer Res Commun. 2024. PMID: 39311710 Free article.
Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer.
Williams MM, Spoelstra NS, Arnesen S, O'Neill KI, Christenson JL, Reese J, Torkko KC, Goodspeed A, Rosas E, Hanamura T, Sams SB, Li Z, Oesterreich S, Riggins RB, Jacobsen BM, Elias A, Gertz J, Richer JK. Williams MM, et al. Among authors: spoelstra ns. Cancer Res. 2021 Feb 1;81(3):732-746. doi: 10.1158/0008-5472.CAN-20-1200. Epub 2020 Nov 12. Cancer Res. 2021. PMID: 33184106 Free PMC article.
42 results